13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001795097
Total reported value
$544.2M
$544.2M
82 檔
35.3%
During the Q3 2024 filing period, Privium Fund Management B.V. (CIK: 0001795097) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $544.2M across 82 reported positions.
During Q3 2024, Privium Fund Management B.V.'s portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TSLA | Tesla Inc | Stock-Consumer Disc | 14.03% | +0.44% | +1.41% | |
| 2 | SPOT | Spotify Technology S.A. | Stock-Comm Services | 13.67% | -2.12% | -0.67% | |
| 3 | SHOP | Shopify Inc - Class A | Stock-Tech | 8.23% | -2.29% | — | |
| 4 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 6.56% | +0.71% | — | |
| 5 | ASTS | Ast Spacemobile Inc | Stock-Tech | 5.34% | -0.13% | — | |
| 6 | SE | Sea Ltd-adr | Stock-Comm Services | 4.93% | -2.38% | EXIT | |
| 7 | PLTR | Palantir Technologies Inc-a | Stock-Tech | 4.38% | -1.80% | +6.74% | |
| 8 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 3.35% | +0.49% | -3.61% | |
| 9 | SNOW | Snowflake Inc | Stock-Tech | 2.71% | — | -26.36% | |
| 10 | ✓ | Proqr Therapeutics N.v. | Stock-Other | 2.55% | +0.05% | +0.93% | |
| 11 | IONS | Ionis Pharmaceuticals Inc | Stock-Healthcare | 2.50% | +0.13% | +1.41% | |
| 12 | NVDA | Nvidia CORP | Stock-Tech | 2.20% | +0.04% | +28.07% | |
| 13 | ITCIEUR | Intra-cellular Therapies Inc | Stock-Other | 2.15% | — | — | |
| 14 | DDOG | Datadog Inc - Class A | Stock-Tech | 1.88% | — | — | |
| 15 | AMD | Advanced Micro Devices | Stock-Tech | 1.80% | +3.99% | +18.92% | |
| 16 | AXSM | Axsome Therapeutics Inc | Stock-Healthcare | 1.79% | -0.27% | +7.94% | |
| 17 | MRK | Merck & Co. Inc. | Stock-Healthcare | 1.70% | — | +37.25% | |
| 18 | GOOGL | Alphabet Inc-cl A | Stock-Comm Services | 1.65% | — | — | |
| 19 | ARWR | Arrowhead Pharmaceuticals In | Stock-Healthcare | 1.61% | -1.28% | +16.18% | |
| 20 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 1.39% | — | — | |
| 21 | RCKT | Rocket Pharmaceuticals Inc | Stock-Other | 1.35% | -0.03% | +17.46% | |
| 22 | ZLAB | Zai Lab Ltd-adr | Stock-Other | 1.29% | -0.09% | -0.08% | |
| 23 | CPNG | Coupang Inc | Stock-Consumer Disc | 1.24% | — | — | |
| 24 | NET | Cloudflare Inc - Class A | Stock-Tech | 1.21% | — | -14.29% | |
| 25 | MSFT | Microsoft CORP | Stock-Tech | 1.07% | — | — | |
| 26 | OXY | Occidental Petroleum CORP | Stock-Energy | 1.04% | — | — | |
| 27 | QURE | uniQure N.V. | Stock-Other | 0.91% | +1.12% | +16.32% | |
| 28 | MRNA | Moderna Inc | Stock-Healthcare | 0.67% | +0.07% | +74.03% | |
| 29 | ACAD | Acadia Pharmaceuticals Inc | Stock-Healthcare | 0.57% | — | — | |
| 30 | ABEV | Ambev Sa-adr | Stock-Consumer Staples | 0.38% | -0.12% | -2.14% | |
| 31 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 0.35% | +0.03% | +10.97% | |
| 32 | RNAGBP | Avidity Biosciences Inc | Stock-Other | 0.29% | — | +15.10% | |
| 33 | KRYS | Krystal Biotech Inc | Stock-Healthcare | 0.29% | +0.16% | -1.09% | |
| 34 | FDMT | 4d Molecular Therapeutics In | Stock-Other | 0.26% | -0.11% | +146.25% | |
| 35 | ALXO | Alx Oncology Holdings Inc | Stock-Other | 0.23% | — | +28.24% | |
| 36 | MGTX | MeiraGTx Holdings plc | Stock-Other | 0.22% | +0.11% | +4.90% | |
| 37 | C | Citigroup Inc | Stock-Financials | 0.20% | — | +2.61% | |
| 38 | FNV | Franco-nevada CORP | Stock-Materials | 0.19% | — | +155.74% | |
| 39 | BYND 0 03-15-27Bond | Beyond Meat Inc | Bond | 0.18% | — | — | |
| 40 | AUTL | Autolus Therapeutics PLC | Stock-Other | 0.17% | +0.01% | +15.56% | |
| 41 | PFE | Pfizer Inc | Stock-Healthcare | 0.16% | -0.31% | EXIT | |
| 42 | NOV | Nov Inc | Stock-Energy | 0.15% | -0.02% | -4.52% | |
| 43 | AIG | American International Group | Stock-Financials | 0.15% | — | -5.48% | |
| 44 | BTU | Peabody Energy CORP | Stock-Energy | 0.14% | — | +38.71% | |
| 45 | PAAS | Pan American Silver CORP | Stock-Materials | 0.14% | -0.04% | EXIT | |
| 46 | AZEK | Azek Co Inc/the | Stock-Other | 0.13% | — | +34.30% | |
| 47 | DYN | Dyne Therapeutics Inc | Stock-Other | 0.13% | — | +7.13% | |
| 48 | SEA1EUR | Seabridge Gold Inc | Stock-Other | 0.13% | -0.15% | EXIT | |
| 49 | RXRX | Recursion Pharmaceuticals-a | Stock-Healthcare | 0.13% | — | +50.00% | |
| 50 | TILE | Interface Inc | Stock-Other | 0.13% | — | — |
According to official SEC Form 13F filings, Privium Fund Management B.V. reported a total U.S. public equity portfolio value of $544.2M across 82 disclosed positions in Q3 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including TSLA, SPOT, SHOP) accounted for 35.3% of total reported equity market value during Q3 2024.
During Q3 2024, Privium Fund Management B.V.'s top holdings by market value included TSLA (14.0%)、SPOT (13.7%)、SHOP (8.2%). The largest single position, TSLA, represented 14.0% of total portfolio value.
In Q3 2024, Privium Fund Management B.V. made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.